Far-UV Sanitisation of Working Spaces

Aerocare航空服务有限公司（AAS）已经获得了新的远紫外线技术，这将对减轻几乎社会各个方面的病原体传播产生严重影响。考虑到所造成的经济损失、损失的企业数量、完全封锁对社会的影响，这种技术的市场将是巨大的，它对社会的积极影响将是显著和直接的。我们打算采用的准分子波Sterilray（TM）可以显著减少我们生活空间中的病原体（细菌，病毒或其他可能导致疾病的微生物）。我们的目标是通过改善人们在旅行中暴露的环境，使商业航空业成为一个更安全的地方。紫外线波形并不是什么新鲜事，因为UV-C已经被用于消毒多年了。紫外线能够消除99.98%的世界上最有害的细菌，病毒和孢子在气流中与“单程杀死”。EWS光子使细菌和孢子的侧壁破裂，使空气中的病原体浓度低于传染性水平。凭借无与伦比的速度、方便性、有效性和安全性，紫外线产品正在改变空气和表面消毒的世界。准分子波Sterilray（TM）光子只需五分之一秒即可摧毁有害细菌、病毒和孢子。该技术的独特之处在于，它的工作没有损害人类的威胁，在同一个空间（皮肤和眼睛安全）在医学测试中证明。原子吸收光谱法的目标是把开创性的使用专利准分子波Sterilray（tm）技术到欧洲。潜在的市场包括：\* 医院\* 救护车服务\* 诊所\* 牙医\* 洁净室\* 手术室\* 实验室\* 农业\* 港口和机场\* 企业AAS打算首先为航空公司和机场开发清洁服务，用于民用区域和机舱内消毒，并在欧洲市场的许可下生产。该项目将开发用于密闭空间的系统，以及使用远紫外线技术确保运输模式快速，非化学消毒的过程。AAS将与位于弗雷克瑟姆的Glyndwr大学合作，了解远紫外线在快速清洁操作中的效果，以及它提供全面解决方案的能力，使乘客能够快速重新开始航空旅行，增强信心。更新的可交付成果：Aerocare已经交付了最初的项目交付成果。我们现在有经验数据证明远紫外线在航空快速清洁操作中的消毒效果。我们还有数据可以告知清洁程序，包括每平方米所需的“停留”时间。这将使可信的营销方法，使飞机运营商和航空公司与额外的资金，我们将能够：-* 开发两个手推车和大门，以预生产的变种，包括设计，供应链和提供可选的额外 * 法院早期采用者，并获得宝贵的营销见解和曝光，通过贝塔测试和现场演示。我们已经有合作伙伴愿意参与这项测试，并帮助营销结果。* 在实验室条件下进行分类测试，以确定灯的辐照度与功率和距离，以确保我们可以在当前（和未来）的监管环境中工作并保证安全。这将与邓迪的Ninewells医院一起完成，该医院已经在使用远紫外线灯进行皮肤安全工作，并了解开展这项工作所需的流程。根据我们所学到的知识以及门和消毒推车的生产变体，开发更高质量的营销材料

Aerocare Aviation Services Ltd (AAS) have accessed new Far-UV Technology that will make a serious impact on mitigating the transmission of pathogens for almost EVERY facet of society. In the light of the financial loses being incurred, the number of businesses lost, the impact on society of complete lock-downs, the market for this type of technology will be vast, and it's positive impact on society will be significant and immediate. The Excimer Wave Sterilray(tm) which we intend to adapt significantly reduces pathogens (a bacterium, virus or other microorganism that can cause disease) in our living space. It is our goal to make the commercial airline industry a safer place by improving the environment to which people are exposed during their travels.UV waveforms are not new, as UV-C they have been used to sanitise for some years now. UV is capable of eliminating 99.98% of the world's most harmful bacteria, viruses, and spores in an airstream with "Single-Pass Kill". EWS photons rupture sidewall of bacteria and spores, keeping airborne pathogen concentrations below infectivity level. With unmatched speed, convenience, effectiveness, and safety UV products are changing the world of air and surface disinfection.One fifth of a second is all it takes for Excimer Wave Sterilray(tm) photons to destroy harmful bacteria, viruses, and spores. The technology is unique in that it works without threat of damage to humans in the same space (both skin and eye safe) as demonstrated in medical testing.AAS are aiming to bring ground-breaking use of patented Excimer Wave Sterilray(tm) technology to Europe. Potential markets include:\*Hospitals\*Ambulance Services\*Clinics\*Dentists\*Clean Rooms\*Operating Theatres\*Laboratories\*Agriculture\*Ports & Airports\*OfficesAAS intend to develop a cleaning service initially for airlines, and airports, for civil areas and in-cabin sanitisation, and beyond that to manufacture under license for the European market. This Project will develop the system for use in confined spaces, and the processes to ensure rapid, non-chemical disinfection for transport modes using Far-UV technologies. AAS will work with Glyndwr University at Wrexham to understand the effect of the Far-UV in rapid cleaning operations and it's ability to provide a comprehensive solution to enable rapid re-start of air travel with enhanced confidence for passengers.The Updated Deliverables:Aerocare have delivered the initial project deliverables. We now have empirical data that proves the sterilisation effect of Far UV in rapid cleaning operations for aviation. We also have data that will inform cleaning procedures including required 'dwell' periods per metre sq. which will enable credible marketing approaches to be made to aircraft operators and airlinesWith the additional funding we will be able to: -* Develop both the trolley AND the gate to pre-production variants including design, supply chain and provision for optional extras * Court early adopters and to gain valuable marketing insights and exposure through BETA testing and live demonstrations. We already have partners willing to participate in that testing and to help with marketing of the results. * Perform categorisation testing under laboratory conditions to determine the irradiance of the lamps vs power and stand-off to ensure we can work within current (and future) regulatory environments and guarantee safety. This will be completed with Ninewells Hospital in Dundee who are already working on skin safety using FAR-UV lamps and are aware of the required processes to undertake this work.*Develop higher-quality marketing materials based on what we have learned and the production variants of the gates and the sanitisation trolley